The Effect of Macronutrients on Satiety and Gut Hormone Responses
NCT ID: NCT03466047
Last Updated: 2020-10-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2018-03-15
2019-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is that the intake of high quantity of protein in a microcapsule form would be able to reach the distal parts of the intestinal mucosa and stimulate maximum stimulation of the anorectic gut hormones. The higher functions of the brain will respond to these strong neuroendocrine signals by ensuing satiety and fullness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Prebiotic and Synbiotic Supplementation in Individuals Undergoing Roux-en-y Gastric Bypass.
NCT02158676
Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery
NCT00560846
Effect of Oral Nutritional Supplements With Specialized Nutrients on Functional Recovery and Morbidity After Gastrointestinal Surgery
NCT00546975
Efficacy of a Novel Multivitamin-Mineral Supplement in Preventing Vitamin Deficiency in Postoperative Bariatric Patients
NCT01475617
Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients
NCT03787537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Protein stomach
Encapsulated protein released in the stomach
Protein stomach
encapsulated protein stomach
Protein distal small intestine
Encapsulated protein released in the distal small intestine
Protein distal small intestine
encapsulated protein distal small intestine
CHO stomach
Encapsulated CHO released in the stomach
CHO stomach
encapsulated CHO stomach
CHO distal small intestine
Encapsulated CHO released in the distal small intestine
CHO distal small intestine
encapsulated CHO distal small intestine
Fat stomach
Encapsulated Fat released in the stomach
Fat stomach
encapsulated Fat stomach
Fat distal small intestine
Encapsulated Fat released in the distal small intestine
Fat distal small intestine
encapsulated Fat distal small intestine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protein stomach
encapsulated protein stomach
Protein distal small intestine
encapsulated protein distal small intestine
CHO stomach
encapsulated CHO stomach
CHO distal small intestine
encapsulated CHO distal small intestine
Fat stomach
encapsulated Fat stomach
Fat distal small intestine
encapsulated Fat distal small intestine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal fasting glucose
* Stable body weight for at least last three months
* BMI \< 30 Kg/m2
* Capacity to consent to participate
* Independently mobile
Exclusion Criteria
* Pre-diabetes Diabetes
* Obesity
* Smoking
* Substance abuse
* Pregnancy
* Use of medications (except for oral contraceptives)
* Chronic medical or psychiatric illness
* Any significant abnormalities detected on physical examination, electrocardiography, or screening blood tests (measurement of complete blood count, electrolytes, fasting glucose, and liver function)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carel Le Roux
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carel le Roux
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Centre
Dublin, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Microcapsule
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.